关注
Monika Belickova
Monika Belickova
Institute Hematology and Blood Tranfusion
在 uhkt.cz 的电子邮件经过验证
标题
引用次数
引用次数
年份
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ...
Nature medicine 26 (10), 1549-1556, 2020
5092020
Molecular international prognostic scoring system for myelodysplastic syndromes
E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ...
NEJM evidence 1 (7), EVIDoa2200008, 2022
4842022
Differential expression of microRNAs in hematopoietic cell lineages
M Merkerova, M Belickova, H Bruchova
European journal of haematology 81 (4), 304-310, 2008
3072008
Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome
M Dostalova Merkerova, Z Krejcik, H Votavova, M Belickova, A Vasikova, ...
European journal of human genetics 19 (3), 313-319, 2011
1132011
MicroRNA expression profiles in umbilical cord blood cell lineages
M Merkerova, A Vasikova, M Belickova, H Bruchova
Stem cells and development 19 (1), 17-26, 2010
1052010
Clonality in juvenile chronic myelogenous leukemia
L Busque, DG Gilliland, JT Prchal, CA Sieff, HJ Weinstein, JM Sokol, ...
951995
Differential expression of microRNAs in CD34+ cells of 5q-syndrome
H Votavova, M Grmanova, M Dostalova Merkerova, M Belickova, ...
Journal of hematology & oncology 4, 1-6, 2011
842011
Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism.
JT Prchal, JF Prchal, M Belickova, S Chen, Y Guan, GL Gartland, ...
The Journal of experimental medicine 183 (2), 561-567, 1996
671996
TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes
M Belickova, J Vesela, A Jonasova, B Pejsova, H Votavova, ...
Oncotarget 7 (24), 36266, 2016
622016
5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU. 1 gene and cell differentiation capacity
N Curik, P Burda, K Vargova, V Pospisil, M Belickova, P Vlckova, ...
Leukemia 26 (8), 1804-1811, 2012
582012
A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome
A Vasikova, M Belickova, E Budinska, J Cermak
Leukemia Research 34 (12), 1566-1572, 2010
512010
Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.
H Cechova, P Lassuthova, L Novakova, M Belickova, R Stemberkova, ...
Neoplasma 59 (2), 168-174, 2012
382012
Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with …
K Svobodova, Z Zemanova, H Lhotska, M Novakova, L Podskalska, ...
Leukemia research 42, 7-12, 2016
372016
Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome
A Hrustincova, Z Krejcik, D Kundrat, K Szikszai, M Belickova, ...
Cells 9 (4), 794, 2020
352020
A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55.
M Luhovy, Y Liu, M Belickova, JF Prchal, JT Prchal
Biology of Blood and Marrow Transplantation: Journal of the American Society …, 1995
281995
Genome‐wide mi RNA profiling in myelodysplastic syndrome with del (5q) treated with lenalidomide
MD Merkerova, Z Krejcik, M Belickova, A Hrustincova, J Klema, E Stara, ...
European Journal of Haematology 95 (1), 35-43, 2015
272015
Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome
B Stiburkova, K Pavelcova, M Belickova, SJ Magaziner, JC Collins, ...
Arthritis & Rheumatology 75 (7), 1285-1290, 2023
262023
MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia
Z Krejcik, M Belickova, A Hrustincova, H Votavova, A Jonasova, J Cermak, ...
Cancer Biomarkers 22 (1), 101-110, 2018
232018
DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population
M Belickova, MD Merkerova, E Stara, J Vesela, D Sponerova, ...
Journal of Hematology & Oncology 6, 1-6, 2013
232013
Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q-syndrome and in Diamond–Blackfan anemia
R Neuwirtova, O Fuchs, M Holicka, M Vostry, A Kostecka, H Hajkova, ...
Annals of hematology 92, 11-18, 2013
232013
系统目前无法执行此操作,请稍后再试。
文章 1–20